VEGF is intimately involved with the progression of proliferative DR and diabetic macular edema facilitating changes in retinal capillary permeability, and advances in anti-VEGF therapies, in age-related macular degeneration, have accelerated the application of anti-VEGF therapies in DR [9]. Here, VEGFA is linked to age-related macular degeneration.